Table 5.

Correlates of depression treatment among middle-aged and older adults (50 years and older) meeting major depression criteria

	PHARMACOTHERAPYa		PSYCHOTHERAPYb		ANY THERAPYc
	OR	95% CI	OR	95% CI	OR	95% CI
Ethnicity/race
Non-Latino Whites	Ref	n/a	Ref	n/a	Ref	n/a
Cubans	0.85	0.54–1.33	1.28	0.78–2.10	0.88	0.50–1.56
Puerto Ricans	0.64	0.23–1.78	0.94	0.39–2.28	0.98	0.45–2.13
Mexicans	0.38	0.11–1.38	0.79	0.35–1.76	0.47	0.21–1.03
Blacks	0.68	0.39–1.17	1.41	0.85–2.33	0.97	0.60–1.59
Depression type
MDDd	Ref	n/a	Ref	n/a	Ref	n/a
Comorbid CVD/MDDe	0.74	0.40–1.36	0.93	0.53–1.63	0.87	0.52–1.48
Sex
Female	Ref	n/a	Ref	n/a	Ref	n/a
Male	1.22	0.61–2.45	1.35	0.66–2.76	1.11	0.57–2.18
Age
50–64	Ref	n/a	Ref	n/a	Ref	n/a
65+	0.72	0.39–1.31	0.36***	0.20–0.64	0.51**	0.28–0.92

^aAntidepressant prescription drug use based on respondent report and pill bottle inventory reviews.

^bSelf-reported treatment by a mental health professional including by a psychiatrist, psychologist, counselor, or social worker.

^cEither pharmacotherapy or psychotherapy.

^dMeeting criteria for lifetime major depression, based on World Mental Health Composite International Diagnostic Interviews, with a depressive episode occurring at age 50 years or older and no reported cerebrovascular diseases.

^eMeeting criteria for a lifetime major depressive disorder (MDD) with a depressive episode occurring at age 50 years or older, and self-reported medical diagnoses of one or more cerebrovascular disease (including diabetes, hypertension, heart disease, or stroke).

^**p < 0.05.

^***p < 0.01.

Results are from logistic regressions using data from the Collaborative Psychiatric Epidemiology Surveys.